Retracted: Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-κB Signalling Pathway

Jiantao He; Wei Wei; Qingbo Yang; Yiling Wang

doi:10.12659/MSM.932333

Retracted: Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-κB Signalling Pathway

Med Sci Monit. 2021 Mar 25:27:e932333. doi: 10.12659/MSM.932333.

Authors

Jiantao He¹, Wei Wei², Qingbo Yang¹, Yiling Wang¹

Affiliations

¹ Department of Thoracic Surgery, Shanghai Tenth People's Hospital, Shanghai, China (mainland).
² Department of Emergency, Shanghai Tenth People's Hospital, Shanghai, China (mainland).

Abstract

An editorial decision has been made to retract this manuscript due to breach of publishing guidelines, following the identification of non-original and manipulated figures. Reference: Jiantao He, Wei Wei, Qingbo Yang, Yiling Wang: Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-kappaB Signalling Pathway. Med Sci Monit 2019; 25:739-745. 10.12659/MSM.913138.

Publication types

Retraction of Publication